Concepedia

Mitali Chattopadhyay

MC

27

Publications

1.4K

Citations

21

H-Index

2004

Active since

Affiliations

City University of New York(Current)

New York Institute of Technology

New York Medical College

University of Alberta

National Cancer Institute

Mitali Chattopadhyay is an author at City University of New York specializing in pharmacology, medicine, and cancer research.

Top concepts

Publications per year

2004–2022

27

Publications

27

NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals

Ravinder Kodela, Mitali Chattopadhyay, Khosrow Kashfi · ACS Medicinal Chemistry Letters · 2012 · 173 citations

, , +15

Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: A general property and evidence of a tissue type-independent effect

Mitali Chattopadhyay, Ravinder Kodela, Niharika Nath et al. · Biochemical Pharmacology · 2011 · 129 citations

, , +8

NOSH–aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model

Mitali Chattopadhyay, Ravinder Kodela, Kenneth R. Olson et al. · Biochemical and Biophysical Research Communications · 2012 · 127 citations

, , +8

1α, 25-dihydroxyvitamin D<sub>3</sub>prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital

Mahendrakumar Chandrasekharappa Banakar, Suresh Kanna Paramasivan, Mitali Chattopadhyay et al. · World Journal of Gastroenterology · 2004 · 99 citations · Full text

Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo

Mitali Chattopadhyay, Ravinder Kodela, Niharika Nath et al. · Biochemical Pharmacology · 2011 · 96 citations

, , +12

Rows per page

1–5 of 27